EPM
Equitec Proprietary Markets’s PharmaCyte Biotech PMCB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.2K | Hold |
82,727
| – | – | 0.09% | 16 |
|
|
2025
Q1 | $103K | Hold |
82,727
| – | – | 0.07% | 15 |
|
|
2024
Q4 | $130K | Hold |
82,727
| – | – | 0.13% | 12 |
|
|
2024
Q3 | $158K | Hold |
82,727
| – | – | 0.13% | 10 |
|
|
2024
Q2 | $162K | Hold |
82,727
| – | – | 0.21% | 13 |
|
|
2024
Q1 | $196K | Hold |
82,727
| – | – | 0.12% | 20 |
|
|
2023
Q4 | $179K | Hold |
82,727
| – | – | 0.13% | 22 |
|
|
2023
Q3 | $174K | Buy |
82,727
+21,312
| +35% | +$44.8K | 0.04% | 28 |
|
|
2023
Q2 | $176K | Sell |
61,415
-269,279
| -81% | -$770K | 0.05% | 32 |
|
|
2023
Q1 | $962K | Hold |
330,694
| – | – | 0.45% | 17 |
|
|
2022
Q4 | $969K | Hold |
330,694
| – | – | 0.31% | 23 |
|
|
2022
Q3 | $794K | Sell |
330,694
-12,300
| -4% | -$29.5K | 0.21% | 30 |
|
|
2022
Q2 | $768K | Buy |
342,994
+33,700
| +11% | +$75.5K | 0.22% | 33 |
|
|
2022
Q1 | $711K | Buy |
309,294
+50,600
| +20% | +$116K | 0.16% | 31 |
|
|
2021
Q4 | $647K | Buy |
+258,694
| New | +$647K | 0.09% | 36 |
|